Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

NCT05040360 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

141

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Malignant Neoplasm in the Liver
Pancreatic Neuroendocrine Tumor
Stage I Pancreatic Neuroendocrine Tumor AJCC v8
Stage II Pancreatic Neuroendocrine Tumor AJCC v8
Stage III Pancreatic Neuroendocrine Tumor AJCC v8

Interventions

DRUG: Capecitabine
DRUG: Temozolomide

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]